DnB Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-93,246
Closed -$9.26M 666
2019
Q3
$9.26M Buy
93,246
+5,292
+6% +$503K 0.1% 156
2019
Q2
$8.13M Sell
87,954
-7,416
-8% -$704K 0.09% 173
2019
Q1
$9M Sell
95,370
-71,669
-43% -$6.27M 0.1% 146
2018
Q4
$10.7M Buy
167,039
+75,002
+81% +$5.54M 0.14% 125
2018
Q3
$8.24M Buy
92,037
+304
+0.3% +$26.9K 0.09% 157
2018
Q2
$7.29M Buy
91,733
+3,400
+4% +$282K 0.09% 158
2018
Q1
$7.88M Sell
88,333
-55,600
-39% -$5.34M 0.09% 157
2017
Q4
$15M Buy
143,933
+63,655
+79% +$7.18M 0.18% 97
2017
Q3
$11.7M Sell
80,278
-1,700
-2% -$232K 0.16% 106
2017
Q2
$10.6M Hold
81,978
0.16% 104
2017
Q1
$10.2M Buy
81,978
+6,600
+9% +$790K 0.16% 110
2016
Q4
$8.73M Buy
75,378
+6,100
+9% +$679K 0.16% 117
2016
Q3
$7.24M Buy
69,278
+3,700
+6% +$400K 0.14% 128
2016
Q2
$6.47M Sell
65,578
-29,200
-31% -$3.02M 0.14% 131
2016
Q1
$9.49M Buy
94,778
+54,200
+134% +$5.58M 0.2% 99
2015
Q4
$4.86M Sell
40,578
-1,100
-3% -$127K 0.1% 146
2015
Q3
$4.51M Sell
41,678
-100
-0.2% -$12.4K 0.11% 137
2015
Q2
$4.84M Buy
41,778
+1,600
+4% +$183K 0.11% 147
2015
Q1
$4.63M Buy
40,178
+100
+0.2% +$11.9K 0.1% 155
2014
Q4
$4.48M Sell
40,078
-4,400
-10% -$464K 0.1% 150
2014
Q3
$4.22M Sell
44,478
-8,300
-16% -$749K 0.09% 151
2014
Q2
$4.53M Buy
+52,778
New +$4.01M 0.1% 146
2013
Q4
$2.23M Sell
26,378
-7,600
-22% -$601K 0.05% 168
2013
Q3
$2.62M Sell
33,978
-12,400
-27% -$869K 0.07% 123
2013
Q2
$2.71M Buy
+46,378
New +$2.79M 0.08% 113

Other funds holding CELG

DnB Asset Management's CELG Position: Q4 2019 in Review

DnB Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 93,246 shares — an estimated $9.26M sold.

DnB Asset Management first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $15M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • DnB Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • DnB Asset Management sold 93,246 Celgene Corp shares in Q4 2019, an estimated $9.26M.
  • DnB Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • DnB Asset Management's Celgene Corp position peaked at $15M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on DnB Asset Management's 13F filing for Q4 2019, filed 13 Jan 2020.